Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Acute, dose–response effects of guayusa leaf extract on mood, cognitive and motor-cognitive performance, and blood pressure, heart rate, and ventricular repolarization

Open access

Abstract

An emerging sector of the nootropic market is tea-based nutraceutical products, but there are limited data assessing the dose-dependent effects of these products.Purpose We conducted a randomized, double-blind, placebo-controlled crossover trial in young adults to examine the dose-dependent (600 mg versus 1200 mg), acute effects of consumption of an Ilex guayusa tea extract (GLE) on mood, cognitive and motor-cognitive performance, as well as its acute cardiovascular effects.Methods Twenty-five adults (mean ± SD, age = 28 ± 7 y; 9 M/16 F) completed familiarization and then three randomly ordered experimental visits where they consumed either 600 mg (GLE600) or 1200 mg (GLE1200) GLE or placebo (PLA). Following supplement consumption, participants completed a mood state survey, assessments of perceived jitteriness, energy, and focus, and neurocognitive and motor-cognitive testing. Blood pressure (BP), heart rate, and QT interval length were determined before and after supplementation.Results GLE600 significantly improved total mood disturbance (mean ± SE difference = -6.9 ± 2.6 au, p = 0.034), fatigue-inertia (−2.84 ± 0.89 au, p = 0.008), perceived energy (+13.00 ± 4.49 au; p = 0.02), motor speed (+4.52 ± 1.42 au, p = 0.008), and psychomotor speed (+7.20 ± 2.16 au, p = 0.005) relative to PLA. GLE1200 also improved psychomotor speed (+5.08 ± 2.16 ms, p = 0.045) and uniquely increased motor-cognitive performance as reflected by a decrease in reaction time (−0.106 ± 0.04 ms, p = 0.026) during a neurocognitive hop test. The effect of GLE on jitteriness was both dose- and sex-dependent. Jitteriness increased with increasing GLE dose in women only (p < 0.001). Both GLE600 and GLE1200 similarly increased systolic and diastolic BP by 4–5 mmHg (p ≤ 0.022). Neither GLE600 nor GLE1200 acutely influenced QTc length (p = 0.31).Conclusions The goal of GLE supplementation should be considered when selecting a dosing strategy. Lower dosages of GLE (e.g. 600 mg) appear to optimize cognitive and mood-related outcomes while limiting side-effects such as jitteriness in women, and higher dosages may be necessary (e.g. 1200 mg) to promote improvements in motor-cognitive performance.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/15502783.2024.2379424

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. CONSORT flow diagram depicting the flow of participants through the study from initial screening to data analysis. Figure created with BioRender.com.
Figure 1. CONSORT flow diagram depicting the flow of participants through the study from initial screening to data analysis. Figure created with BioRender.com.CC BY · PubMed Central
Figure 2. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on perceived energy (panel A), focus (panel B), and jitteriness (panel C) (all n = 25). The effect of treatment determined by one-way ANOVAs are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.
Figure 2. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on perceived energy (panel A), focus (panel B), and jitteriness (panel C) (all n = 25). The effect of treatment determined by one-way ANOVAs are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.CC BY · PubMed Central
Figure 3. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on perceived jitteriness in female (panel A, n = 16) and male (panel B, n = 9) adults. The effect of treatment determined by one-way ANOVAs are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.
Figure 3. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on perceived jitteriness in female (panel A, n = 16) and male (panel B, n = 9) adults. The effect of treatment determined by one-way ANOVAs are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.CC BY · PubMed Central
Figure 4. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on executive function (panel A, n = 25), cognitive flexibility (panel B, n = 25), and complex attention (panel C, n = 24). The effect of treatment determined by one-way ANOVAs are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.
Figure 4. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on executive function (panel A, n = 25), cognitive flexibility (panel B, n = 25), and complex attention (panel C, n = 24). The effect of treatment determined by one-way ANOVAs are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.CC BY · PubMed Central
Figure 5. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on motor-cognitive reaction time during the single-leg peripheral crossover test (n = 25). The effect of treatment determined by a one-way ANOVA is shown in the inset text box. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.
Figure 5. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on motor-cognitive reaction time during the single-leg peripheral crossover test (n = 25). The effect of treatment determined by a one-way ANOVA is shown in the inset text box. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.CC BY · PubMed Central
Figure 6. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on total mood disturbance (panel A), fatigue-intertia (panel B), vigor-activity (panel C), confusion-bewilderment (panel D), and depression-dejection (panel E) (all n = 25). The effect of treatment determined by one-way ANOVAs are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments where appropriate.
Figure 6. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on total mood disturbance (panel A), fatigue-intertia (panel B), vigor-activity (panel C), confusion-bewilderment (panel D), and depression-dejection (panel E) (all n = 25). The effect of treatment determined by one-way ANOVAs are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments where appropriate.CC BY · PubMed Central
Figure 7. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on motor speed (panel A) and psychomotor speed (panel B) (all n = 25). The effect of treatment determined by one-way ANOVAs are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.
Figure 7. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) on motor speed (panel A) and psychomotor speed (panel B) (all n = 25). The effect of treatment determined by one-way ANOVAs are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.CC BY · PubMed Central
Figure 8. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) and time (pre- vs. post-consumption) on systolic blood pressure (panel A), diastolic blood pressure (panel B), heart rate (panel C), and QTc interval (panel D) (all n = 25). Interaction and main effect (as appropriate) are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.
Figure 8. The effect of treatment (GLE600 vs. GLE1200 vs. PLA) and time (pre- vs. post-consumption) on systolic blood pressure (panel A), diastolic blood pressure (panel B), heart rate (panel C), and QTc interval (panel D) (all n = 25). Interaction and main effect (as appropriate) are shown in inset text boxes. P-values from Holm-Sidak’s multiple post-hoc comparisons are shown above brackets between treatments.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Research works printed but not linked: 2

  1. 10.1037/1040-3590.7.1.80 · DOI · Paper page
  2. 10.1002/(SICI)1097-4679(199901)55:1<79:AID-JCLP8>3.0.CO;2-7 · doi:10.1002/(sici)1097-4679(199901)55:1

Cited by

See all 4

Metadata

Authors
Helwig, N. J., Schwager, L. E., Berry, A. C., Zucker, A. C., Venenga, J. S., Sterbenz, S. C., & Jenkins, N. D. M.
Affiliations
University of Iowa (US)
Corresponding author
Jenkins, Nathaniel D.M.
Venue
Journal of the International Society of Sports Nutrition
Published
2024-07-16
Volume
21
Issue
1
Pages
2379424-2379424
ISSN
1550-2783 (ISSN-L)
OpenAlex
W4400743879
Cited by
4
References
42
Citations by year
2026: 1 · 2025: 2 · 2024: 1
FWCI
1.13
Type
journal article
Language
en
Open access
Locations
  • Journal of the International Society of Sports Nutrition (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Applied Food Sciences, Inc
  • National Center For Advancing Translational Sciences
  • National Institutes of Health (UL1TR002537)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Coffee research and impacts
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Bioactive Compounds
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plant Extracts Effects
Keywords
Ilex guayusa, nootropic drugs, nutraceuticals, dose-dependent effects, mood, cognitive performance, psychomotor speed, jitteriness, blood pressure, heart rate, QT interval, ventricular repolarization, caffeine, young adults, sex differences, reaction time, hop tests
MeSH terms
Adult, Affect, Blood Pressure, Cognition, Dose-Response Relationship, Drug, Double-Blind Method, Female, Heart Rate, Humans, Male, Plant Extracts, Plant Leaves, Cross-Over Studies, Dietary Supplements, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acute, dose–response effects of guayusa leaf extract on mood, cognitive and motor-cognitive performance, and blood pressure, heart rate, and ventricular repolarization. https://app.cochat.ai/papers/10.1080/15502783.2024.2379424
The paper
Helwig, N. J., Schwager, L. E., Berry, A. C., Zucker, A. C., Venenga, J. S., Sterbenz, S. C., & Jenkins, N. D. M. (2024). Acute, dose–response effects of guayusa leaf extract on mood, cognitive and motor-cognitive performance, and blood pressure, heart rate, and ventricular repolarization. Journal of the International Society of Sports Nutrition. https://doi.org/10.1080/15502783.2024.2379424

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.